Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer - Related Studies

Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer

This study has been completed.

Study NCT00002562. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cervical Cancer
		Vaginal Cancer

2	Additional conditions recognized in this trial
		Uterine Cervical Neoplasms
		Vaginal Neoplasms

3	More general conditions related to this trial
		Genital Diseases, Female
		Genital Neoplasms, Female
		Neoplasms
		Neoplasms by Site
		Urogenital Neoplasms
		Uterine Cervical Diseases
		Uterine Diseases
		Uterine Neoplasms
		Vaginal Diseases

4	Interventions listed in this trial
		paclitaxel

5	More general drug interventions related to this trial
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses
		Tubulin Modulators

6	Sponsors listed in this trial
		Gynecologic Oncology Group
		National Cancer Institute (NCI)